Pulmatrix Inc: Tumbles on direct stock-and-warrants offering
Brief: Pulmatrix Reports $8.0 Mln Registered Direct Offering Priced At-The-Market
Brief: Pulmatrix And Sensory Cloud Announce Partnership To Develop And Commercialize A Potential Nasal Prophylactic And Anticontagion Product For Covid-19
Pulmatrix: Jumps after granting license for respiratory disease products
Brief: Pulmatrix Inc Enters Into Collaboration And License Agreement With Sensory Cloud Inc
Brief: Pulmatrix Reports 2019 Financial Results And Provides Business Update
Brief: Pulmatrix Receives Fast Track Designation For Pulmazole For The Treatment Of Asthma-Abpa
Brief: Pulmatrix Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. STOCKS ON THE MOVE-Alibaba, Tesla, BlackRock
U.S. STOCKS ON THE MOVE-Tesla, Alibaba, United Airlines
Pulmatrix more than doubles on licensing deal with JNJ's Lung Cancer Initiative
Brief: Pulmatrix Enters Licensing, Development Agreement With Lung Cancer Initiative At Johnson & Johnson
Brief: Kaleido Biosciences Appoints William Duke As Chief Financial Officer
Brief: Pulmatrix Appoints Life Sciences Executive Rick Batycky To The Board Of Directors
Brief: Pulmatrix Reports Q3 2019 Results
Brief: Pulmatrix Says William Duke Jr Tendered His Resignation As CFO
U.S. STOCKS ON THE MOVE-Nio, Altaba, Cellcom Israel, Snap
Brief: Pulmatrix And Cipla Announce First Patient Dosed In Phase 2 Trial Evaluating Pulmazole
Brief: Pulmatrix Receives U.S. Patent Covering iSperse Formulations For Pulmazole Program